{"id":"W1967214137","doi":"10.1172/jci40259","title":"Engaging the lysosomal compartment to combat B cell malignancies","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Investigation","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Response Biomedical (Canada)","funders":"Medical Research Council; Novo Nordisk; H. Lundbeck A/S; Lundbeckfonden; Sundhed og Sygdom, Det Frie Forskningsråd; Danmarks Grundforskningsfond; National Research Foundation; European Commission; Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"CD20; Rituximab; B cell; Programmed cell death; Lymphoma; Medicine; Immunology; Lysosome; Monoclonal antibody; Cancer research; Apoptosis; Antibody; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004145131,0.0003012155,0.001224112,0.0002352593,0.0001283674,0.0001015624,0.0005311571,0.0006481863,0.00006811682],"category_scores_gemma":[0.002612162,0.0001824234,0.0006356445,0.0002976339,0.0003974076,0.0001144416,0.0001036875,0.004823427,0.0001212994],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00291342,"about_ca_system_score_gemma":0.008872088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003195427,"about_ca_topic_score_gemma":0.000002837712,"domain_scores_codex":[0.9938983,0.0008820634,0.002575923,0.0003095273,0.001871295,0.0004628533],"domain_scores_gemma":[0.9940676,0.002642775,0.001465271,0.0005900624,0.0007580568,0.0004762414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001552569,0.00007868072,0.0005501023,0.000175747,0.0001255034,0.001050755,0.0002109845,0.00008309435,0.0002219425,0.00001856285,0.9955717,0.001757692],"study_design_scores_gemma":[0.01035937,0.002399754,0.006895856,0.001833828,0.0006801955,0.001053724,0.0001001416,0.001308733,0.002482675,0.001332953,0.9712428,0.0003099002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2298534,0.0005266057,0.0001198622,0.7667158,0.00108713,0.0006105783,0.000004949101,0.00001933102,0.001062364],"genre_scores_gemma":[0.0912405,0.0001972865,0.002951526,0.8863456,0.01618909,0.0000089398,0.00006671847,0.00005290769,0.002947403],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1386129,"threshold_uncertainty_score":0.9974725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1314796178940679,"score_gpt":0.406458272408917,"score_spread":0.2749786545148492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}